imatinib mesylate has been researched along with Bladder Pain Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garcia-Pascual, A; Lafuente-Sanchis, A; Sancho, M; Triguero, D | 1 |
| Yang, J; Yin, Z | 1 |
2 other study(ies) available for imatinib mesylate and Bladder Pain Syndrome
| Article | Year |
|---|---|
Proliferation of Interstitial Cells in the Cyclophosphamide-Induced Cystitis and the Preventive Effect of Imatinib.
Topics: Animals; Antigens, CD34; Cell Proliferation; Cyclophosphamide; Cystitis, Interstitial; Disease Models, Animal; Female; Imatinib Mesylate; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Receptor, Platelet-Derived Growth Factor alpha | 2017 |
[Bladder interstitial cells and pathophysiology].
Topics: Benzamides; Cystitis, Interstitial; Electric Stimulation; Humans; Imatinib Mesylate; Mucous Membrane; Piperazines; Pyrimidines; Signal Transduction | 2014 |